Literature DB >> 19198840

[Molecular pathology as an necessity: its role in diagnostic and predictive pathology].

K W Schmid1.   

Abstract

Individualized therapeutic regimes are almost exclusively based on the rapid developments in molecular pathology. Application of (additional) molecular pathological investigations may thus offer the unique opportunity to improve the classical morphologic diagnosis as well as to routinely evaluate the parameters ("biomarkers") required for therapeutic decision making. Pathologists are thus facing the cogent necessity to perform and develop molecular pathological investigations in high quality and to establish biobanks, as well as to adjust their specialist training accordingly in order to meet these requirements.

Mesh:

Substances:

Year:  2009        PMID: 19198840     DOI: 10.1007/s00292-008-1109-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  18 in total

Review 1.  Advances in microRNAs: implications for gene therapists.

Authors:  Rebecca T Marquez; Anton P McCaffrey
Journal:  Hum Gene Ther       Date:  2008-01       Impact factor: 5.695

2.  Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series.

Authors:  Christine Desmedt; Fanny Piette; Sherene Loi; Yixin Wang; Françoise Lallemand; Benjamin Haibe-Kains; Giuseppe Viale; Mauro Delorenzi; Yi Zhang; Mahasti Saghatchian d'Assignies; Jonas Bergh; Rosette Lidereau; Paul Ellis; Adrian L Harris; Jan G M Klijn; John A Foekens; Fatima Cardoso; Martine J Piccart; Marc Buyse; Christos Sotiriou
Journal:  Clin Cancer Res       Date:  2007-06-01       Impact factor: 12.531

Review 3.  Using high-throughput SNP technologies to study cancer.

Authors:  L J Engle; C L Simpson; J E Landers
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

Review 4.  SNP genotyping: technologies and biomedical applications.

Authors:  Sobin Kim; Ashish Misra
Journal:  Annu Rev Biomed Eng       Date:  2007       Impact factor: 9.590

5.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

Review 6.  Clinical proteomics in breast cancer: a review.

Authors:  Marie-Christine W Gast; Jan H M Schellens; Jos H Beijnen
Journal:  Breast Cancer Res Treat       Date:  2008-12-11       Impact factor: 4.872

Review 7.  MicroRNAs: control and loss of control in human physiology and disease.

Authors:  Min Li; Christian Marin-Muller; Uddalak Bharadwaj; Kwong-Hon Chow; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

Review 8.  Biomarkers for prostate cancer.

Authors:  Eric Schiffer
Journal:  World J Urol       Date:  2007-08-10       Impact factor: 4.226

9.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

Review 10.  Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening.

Authors:  Dean H Conrad; Jesse Goyette; Paul S Thomas
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.